幹細胞の世界市場レポート 2025

幹細胞市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.4％で259億2,000万米ドルに成長します。予測期間の成長は、がん領域における用途の拡大、個別化医療におけるイノベーション、政府による支援と資金提供、バイオテクノロジーとの提携やパートナーシップ、臨床試験、規制当局による承認などに起因すると考えられます。予測期間の主な動向には、幹細胞療法の商業化、CRISPR技術の応用、規制枠組みの開発、幹細胞研究への投資、エクソソーム治療薬への注目などがあります。

世界の慢性疾患の有病率の上昇が幹細胞市場の成長に拍車をかけています。幹細胞治療では、幹細胞を用いて様々な疾患や症状の治療や予防が行われます。骨髄移植が最も広く利用されている幹細胞治療であるが、臍帯血由来の治療もますます一般的になってきています。現在、血液幹細胞の移植は、特に血液疾患や免疫系疾患の治療、あるいはがん治療後の血液システムの回復のために、顕著に応用されています。例えば、2024年4月、英国を拠点とする国家的慈善団体Allergy UKは、英国で2,100万人以上がアレルギーの影響を受けており、2022年に最も多く報告された慢性的な健康状態であると報告しました。予測によれば、2026年までに欧州の人口の半数が少なくとも1つのアレルギーを経験することになります。したがって、世界の慢性疾患の有病率の増加が幹細胞市場の成長を促進しています。

幹細胞市場の成長には、個別化医療に対する需要の高まりがさらに拍車をかけています。個別化医療は、個人特有の遺伝的体質に合わせた治療を行い、より正確で効果的なヘルスケア介入を提供します。幹細胞は、個別化医療の文脈では、損傷した組織を再生・置換する可能性を提供し、個々の患者に合わせた治療を可能にします。2022年、食品医薬品局（FDA）の医薬品評価研究センター（CDER）は37の新規分子実体（NME）を承認し、そのうち約34％（12）は個別化医療連合（PMC）によって個別化医薬品に分類されました。このように、個別化医療に対する需要の高まりが幹細胞市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界幹細胞 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の幹細胞市場：成長率分析
• 世界の幹細胞市場の実績：規模と成長, 2019-2024
• 世界の幹細胞市場の予測：規模と成長, 2024-2029, 2034F
• 世界幹細胞総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の幹細胞市場：ソース別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自家移植
• 同種異系
• 世界の幹細胞市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大人向け幹細胞
• ヒト胚幹細胞
• 誘導多能性幹細胞
• その他の製品
• 世界の幹細胞市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 再生医療
• 医薬品の発見と開発
• 世界の幹細胞市場、自家移植のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 骨髄由来幹細胞
• 脂肪組織由来幹細胞
• 末梢血幹細胞
• 世界の幹細胞市場、同種異系疾患のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 骨髄由来幹細胞
• 臍帯血幹細胞
• ドナーからの末梢血幹細胞

第7章 地域別・国別分析

• 世界の幹細胞市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の幹細胞市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 幹細胞市場：競合情勢
• 幹細胞市場：企業プロファイル
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Cryo-Cell International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group Ltd Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• CellGenix GmbH
• China Cord Blood Corporation
• Organogenesis Holdings Inc.
• LifeCell International
• Cord Blood America Inc.
• StemCyte Inc.
• Cryoviva India
• Cordlife Group Limited
• Thermo Fisher Scientific Inc.
• CordVida
• Cryo Stemcell Inc.
• Pluristem Therapeutics Inc.
• Mesoblast Limited
• Americord Registry LLC
• Smart Cells International

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 幹細胞市場2029：新たな機会を提供する国
• 幹細胞市場2029：新たな機会を提供するセグメント
• 幹細胞市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Stem cells, whether autologous or allogenic, possess the ability to differentiate into various cell types both in vivo and in vitro, making them valuable in the medical treatment of injuries and organ damage.

The primary product categories of stem cells include adult stem cells, human embryonic stem cells, induced pluripotent stem cells, and others. Adult stem cells represent a rare cell population in the body during the majority of postnatal life, capable of giving rise to a limited number of mature cell types that contribute to the formation of the tissue in which they are located. These stem cells can be derived from autologous or allogeneic sources and find applications in diverse areas such as regenerative medicine, drug discovery, and development.

The stem cell market research report is one of a series of new reports from The Business Research Company that provides stem cell market statistics, including stem cell market industry global market size, regional shares, competitors with a stem cell market share, detailed stem cell market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell market industry. This stem cell market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell market size has grown strongly in recent years. It will grow from $15.34 billion in 2024 to $16.85 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to advancements in regenerative medicine, growing prevalence of chronic diseases, research and development initiatives, increasing aging population, rising awareness and acceptance.

The stem cell market size is expected to see rapid growth in the next few years. It will grow to $25.92 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to expanding applications in oncology, innovations in personalized medicine, government support and funding, biotechnology collaborations and partnerships, clinical trials and regulatory approvals. Major trends in the forecast period include commercialization of stem cell therapies, application of CRISPR technology, regulatory framework development, investments in stem cell research, focus on exosome therapeutics.

The rising prevalence of chronic diseases worldwide is fueling growth in the stem cell market. Stem cell therapy involves using stem cells to treat or prevent various diseases and conditions. While bone marrow transplants are the most widely utilized form of stem cell therapy, treatments derived from umbilical cord blood are also becoming increasingly common. Currently, the transplantation of blood stem cells is a prominent application, particularly for treating blood and immune system disorders or for restoring the blood system following cancer treatments. For instance, in April 2024, Allergy UK, a UK-based national charity, reported that over 21 million people in the UK are affected by allergies, making it the most commonly reported chronic health condition in 2022. Projections suggest that by 2026, half of Europe's population will experience at least one allergy. Therefore, the increasing prevalence of chronic diseases worldwide is driving the growth of the stem cell market.

The growth of the stem cell market is further fueled by the increasing demand for personalized medicine. Personalized medicine tailors medical treatment to an individual's unique genetic makeup, providing more precise and effective healthcare interventions. Stem cells, in the context of personalized medicine, offer the potential for regenerating and replacing damaged tissues, allowing for treatments tailored to individual patients. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% (12 of them) classified as personalized medicines by the Personalized Medicine Coalition (PMC). Thus, the rising demand for personalized medicine contributes to the growth of the stem cell market.

Companies operating in the stem cell therapeutics market are concentrating on advancing technologies, such as Induced Pluripotent Stem Cells (IPSC), to enhance the effectiveness of stem cell therapies. IPSCs are derived from blood or skin cells that undergo reprogramming to achieve an embryonic-such as pluripotent state. This process involves the introduction of genes essential for maintaining key properties and promoting the growth of an unlimited source of any human cell type required for stem cell therapeutic purposes. Importantly, IPSCs are not derived from human embryos, addressing bioethical concerns and facilitating easier access to federal funding and support. An illustrative example is the Japanese company Oksara, which inaugurated a medicine center producing cells derived from IPSCs. Similarly, Takar Bio introduced human iPSC-derived Beta Cells, known as Cellartis, designed for disease modeling and drug discovery.

Major companies in the stem cell market are also prioritizing the development of automated stem cell analysis systems to gain a competitive advantage. These systems streamline the assessment of stem cell characteristics and viability, enhancing research and clinical applications with increased efficiency and precision. For instance, in May 2022, Beckman Coulter Inc., a US-based healthcare company, launched the AQUIOS STEM System, a solution specifically engineered for stem cell analysis. This system offers full automation, reducing hands-on time by 95% and minimizing error-prone tasks by 87.5%. Combining the automation capabilities of the AQUIOS CL with a stem cell enumeration solution, it can be customized to meet diverse requirements.

In April 2023, STEMCELL Technologies, a leading biotechnology firm based in Canada, acquired SQZ Biotechnologies Company for an undisclosed amount. This acquisition aims to strengthen STEMCELL's capabilities in delivering cell therapies by leveraging SQZ's innovative mechanoporation technology, which enables the introduction of therapeutic cargo into cells without the use of electricity. SQZ Biotechnologies, located in the United States, specializes in developing advanced methods for delivering therapeutic cargo into cells through this mechanoporation process. SQZ Biotechnologies Co. is recognized as a clinical-stage biotechnology company based in the U.S.

Major companies operating in the stem cell market include Danaher Corporation, Cryo-Cell International Inc., Daiichi Sankyo Company Limited, Lonza Group Ltd, PerkinElmer Inc., CellGenix GmbH, China Cord Blood Corporation, Organogenesis Holdings Inc., LifeCell International, Cord Blood America Inc., StemCyte Inc., Cryoviva India, Cordlife Group Limited, Thermo Fisher Scientific Inc., CordVida, Cryo Stemcell Inc., Pluristem Therapeutics Inc., Mesoblast Limited, Americord Registry LLC, Smart Cells International, Athersys Inc., ReeLabs Pvt. Ltd., Cytori Therapeutics Inc., Esperite N.V., Stemade Biotech, ViaCord, Aldagen Inc, Isto Biologics, Brainstorm Cell Therapeutics Inc.

North America was the largest region in the stem cell market in 2024. Western Europe was the second largest region in the global stem cell market share. The regions covered in the stem cell market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the stem cell market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The stem cell market consists of sales of organoids & 3D Cell Culture, mesenchymal Stem Cells, neural stem cells, hematopoietic stem cells, and cancer stem cells. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stem cell market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Source: Autologous; Allogeneic
• 2) By Product Type: Adult Stem Cell; Human Embryonic Stem Cell; Induced Pluripotent Stem Cell; Other Products
• 3) By Application: Regenerative Medicine; Drug Discovery And Development
• Subsegments:
• 1) By Autologous: Bone Marrow-Derived Stem Cells; Adipose Tissue-Derived Stem Cells; Peripheral Blood Stem Cells
• 2) By Allogeneic: Bone Marrow-Derived Stem Cells; Umbilical Cord Blood Stem Cells; Peripheral Blood Stem Cells From Donors
• Companies Mentioned: Danaher Corporation; Cryo-Cell International Inc.; Daiichi Sankyo Company Limited; Lonza Group Ltd; PerkinElmer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stem Cell Market Characteristics

3. Stem Cell Market Trends And Strategies

4. Stem Cell Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Stem Cell Growth Analysis And Strategic Analysis Framework

• 5.1. Global Stem Cell PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Stem Cell Market Growth Rate Analysis
• 5.4. Global Stem Cell Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Stem Cell Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Stem Cell Total Addressable Market (TAM)

6. Stem Cell Market Segmentation

• 6.1. Global Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous
• Allogeneic
• 6.2. Global Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult Stem Cell
• Human Embryonic Stem Cell
• Induced Pluripotent Stem Cell
• Other Products
• 6.3. Global Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regenerative Medicine
• Drug Discovery And Development
• 6.4. Global Stem Cell Market, Sub-Segmentation Of Autologous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Marrow-Derived Stem Cells
• Adipose Tissue-Derived Stem Cells
• Peripheral Blood Stem Cells
• 6.5. Global Stem Cell Market, Sub-Segmentation Of Allogeneic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Marrow-Derived Stem Cells
• Umbilical Cord Blood Stem Cells
• Peripheral Blood Stem Cells From Donor

7. Stem Cell Market Regional And Country Analysis

• 7.1. Global Stem Cell Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Stem Cell Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stem Cell Market

• 8.1. Asia-Pacific Stem Cell Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stem Cell Market

• 9.1. China Stem Cell Market Overview
• 9.2. China Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stem Cell Market

• 10.1. India Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stem Cell Market

• 11.1. Japan Stem Cell Market Overview
• 11.2. Japan Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stem Cell Market

• 12.1. Australia Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stem Cell Market

• 13.1. Indonesia Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stem Cell Market

• 14.1. South Korea Stem Cell Market Overview
• 14.2. South Korea Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stem Cell Market

• 15.1. Western Europe Stem Cell Market Overview
• 15.2. Western Europe Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stem Cell Market

• 16.1. UK Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stem Cell Market

• 17.1. Germany Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stem Cell Market

• 18.1. France Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stem Cell Market

• 19.1. Italy Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stem Cell Market

• 20.1. Spain Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stem Cell Market

• 21.1. Eastern Europe Stem Cell Market Overview
• 21.2. Eastern Europe Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stem Cell Market

• 22.1. Russia Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stem Cell Market

• 23.1. North America Stem Cell Market Overview
• 23.2. North America Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stem Cell Market

• 24.1. USA Stem Cell Market Overview
• 24.2. USA Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stem Cell Market

• 25.1. Canada Stem Cell Market Overview
• 25.2. Canada Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stem Cell Market

• 26.1. South America Stem Cell Market Overview
• 26.2. South America Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stem Cell Market

• 27.1. Brazil Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stem Cell Market

• 28.1. Middle East Stem Cell Market Overview
• 28.2. Middle East Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stem Cell Market

• 29.1. Africa Stem Cell Market Overview
• 29.2. Africa Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stem Cell Market Competitive Landscape And Company Profiles

• 30.1. Stem Cell Market Competitive Landscape
• 30.2. Stem Cell Market Company Profiles
  • 30.2.1. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Cryo-Cell International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Lonza Group Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Stem Cell Market Other Major And Innovative Companies

• 31.1. CellGenix GmbH
• 31.2. China Cord Blood Corporation
• 31.3. Organogenesis Holdings Inc.
• 31.4. LifeCell International
• 31.5. Cord Blood America Inc.
• 31.6. StemCyte Inc.
• 31.7. Cryoviva India
• 31.8. Cordlife Group Limited
• 31.9. Thermo Fisher Scientific Inc.
• 31.10. CordVida
• 31.11. Cryo Stemcell Inc.
• 31.12. Pluristem Therapeutics Inc.
• 31.13. Mesoblast Limited
• 31.14. Americord Registry LLC
• 31.15. Smart Cells International

32. Global Stem Cell Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stem Cell Market

34. Recent Developments In The Stem Cell Market

35. Stem Cell Market High Potential Countries, Segments and Strategies

• 35.1 Stem Cell Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Stem Cell Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Stem Cell Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer